Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isoflavanone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111574487A details asymmetric hydrogenation for chiral dihydroisoflavones. Offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.